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middle and inferior lobe bronchi ( Figure 1B ). During fiberoptic bronchoscopy, no endobronchial abnormalities were noted ( Figure 1C ). Transbronchial biopsy specimens revealed diffuse infiltration of the lung parenchyma by small and medium-sized lymphoid cells ( Figure 1D ). These cells were CD20-positive and bcl2-positive, but did not co-express CD5, CD10, bcl6, or cyclin D1. Because the systemic examination revealed no other lesions, primary mucosa-associated lymphoid tissue (MALT) lymphoma of the lung was diagnosed. The patient underwent six cycles of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone), resulting in complete remission of the tumor. Primary pulmonary lymphoma represents only 0.5% of all primary lung neoplasms, with pulmonary MALT lymphoma being the most frequent subset. MALT lymphoma manifests as diverse lung abnormality patterns on CT scans; the most common findings are nodules, masses, and patchy consolidations with air bronchogram.
1 MALT lymphoma may also manifest as a solid mass, mimicking lung cancer.
